Normal view

Received — 27 May 2026 ⏭ Nature Cancer

Nature Cancer
Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study Anuradha Jayaram · Memuna Rashid · Alison H. M. Reid · Francesco Orlando · Suparna Thakali · Leila Zakka · Miriam Goncalves · Jacqueline O’Dwyer · Constantine Alifrangis · Rob Jones · Elias Pintus · Sarah Needleman · Diletta Bianchini · Anna Wingate · Kenrick Ng · Mark Linch · Ursula McGovern · John Staffurth · Simon J. Crabb · Susannah Brock · Alison Birtle · Osvaldas Vainauskas · Gianmarco Leone · Millenn Chiwewe · Allan Hackshaw · Andre Lopes · Daniel Wetterskog · Francesca Demichelis · Gerhardt Attard
Nature Cancer, Published online: 15 May 2026; doi:10.1038/s43018-026-01172-9Jayaram et al. assessed the performance of the combination of circulating tumor DNA and serum prostate-specific antigen for dynamic monitoring of metastatic prostate cancer at first-line treatment in this prospective observational clinical trial.
15 May 2026 at 08:00

Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study

By: Anuradha Jayaram · Memuna Rashid · Alison H. M. Reid · Francesco Orlando · Suparna Thakali · Leila Zakka · Miriam Goncalves · Jacqueline O’Dwyer · Constantine Alifrangis · Rob Jones · Elias Pintus · Sarah Needleman · Diletta Bianchini · Anna Wingate · Kenrick Ng · Mark Linch · Ursula McGovern · John Staffurth · Simon J. Crabb · Susannah Brock · Alison Birtle · Osvaldas Vainauskas · Gianmarco Leone · Millenn Chiwewe · Allan Hackshaw · Andre Lopes · Daniel Wetterskog · Francesca Demichelis · Gerhardt Attard

15 May 2026 at 08:00

Nature Cancer, Published online: 15 May 2026; doi:10.1038/s43018-026-01172-9

Jayaram et al. assessed the performance of the combination of circulating tumor DNA and serum prostate-specific antigen for dynamic monitoring of metastatic prostate cancer at first-line treatment in this prospective observational clinical trial.